LifeNet Health is pleased to announce the launch of OraGen, the first viable dental bone allograft material comprised of cryopreserved cortical cancellous bone containing endogenous lineage-committed osteocytes combined with demineralized bone matrix.
This unique composition is at the heart of OraGen’s innovation, as it possesses three essential properties for bone regeneration: osteogenicity, the ability of lineage-committed osteocytes to generate new bone; osteoconductivity, providing a biocompatible scaffold for cell attachment and growth; and osteoinduction, stimulating bone repair by retaining natural growth factors.
OraGen is designed for dental procedures including sinus and alveolar ridge augmentation, and repair of large defects in the mandible or maxilla.
Building on the proven success of LifeNet Health’s advanced cellular allograft technology in bone repair and reconstruction, OraGen redefines the standard for dental tissue engineering and ushers in a new era of innovation and efficiency in bone regeneration.
New bone is rapidly formed and continues to grow upon implantation.
OraGen sets a new standard for safety and convenience. It is sterile and uses a proprietary cryopreservation method that allows for transplant processing within 72 hours to maximize cell viability, 24 hours faster than competing products.
OraGen can also be thawed in five minutes, ensuring fast and convenient preparation in the clinical setting.
OraGen is now available in the U.S. through LifeNet Health’s strategic partner, Salvin Dental Specialties, a trusted leader in dental procedures.
Tailored for advanced dental procedures, OraGen offers revolutionary potential for dentists and their patients.
“We are very excited to be working with Salvin Dental Specialties to bring OraGen to market,” said Daniel Osborne, Chief Growth Officer, LifeNet Health.
This collaboration reflects our commitment to delivering cutting-edge solutions that not only improve patient outcomes, but also advance the field of regenerative medicine. Together, we are not only advancing healing, but also improving lives. ”
“Salvin Dental’s exclusive distribution agreement with LifeNet Health for OraGen® demonstrates our deep commitment to providing our customers with the most comprehensive and innovative regenerative solutions,” said Ken Serota, CEO of Young Innovations.
Salvin’s long-standing partnership with LifeNet Health has been focused on improving patient outcomes through an exceptional commitment to quality and service. We look forward to working together to empower dentists to improve the quality of life for their patients.”
LifeNet Health and Salvin Dental Specialties are committed to achieving these advancements with unparalleled quality and exceptional customer support, and to strengthening their shared mission to raise the standard of surgical dental care.
Related topics:
